THOUSAND OAKS, Calif., Nov. 21, 2013 /PRNewswire/ -- Energy crop company Ceres, Inc. (Nasdaq: CERE) today announced financial results for the fiscal year ended August 31, 2013 and provided an update on its business in Brazil.
The company reported that plantings for the 2013-2014 sorghum growing season in Brazil have commenced and are expected to continue through December. With industrial processing of Ceres' sweet sorghum hybrids generally well established, these plantings consist primarily of smaller, multi-hybrid evaluations designed to determine yield potential, identify the best performing hybrids for specific regions and to demonstrate various crop management practices."Our goal this season is to clearly demonstrate the economic basis for sweet and high biomass sorghum cultivation and processing," said Richard Hamilton, President and Chief Executive Officer of Ceres. "We have made a number of adjustments to our product development process and go-to-market approach, with an emphasis on consistent execution of our crop management protocols."
Mr. Hamilton noted that field performance will largely determine the scale and pace at which the company's products will be adopted moving forward. "We have significantly increased yields of fermentable sugars since our first industrial evaluations in 2011 and we expect to continue to develop a stream of higher-performing hybrids that provide a greater buffer to variable growing conditions and crop management practices," he said.
Ceres Chief Financial Officer Paul Kuc indicated that the company is moving forward with previously reported plans to reduce expenses in fiscal year 2014. "The priority for our working capital will be product development and commercial activities related to sorghum and our near-term opportunity in Brazil. We will also continue to advance potentially high-value traits, like yield and drought resistance, in our pipeline for use in sorghum as well as in row crops," he said.
RECENT BUSINESS HIGHLIGHTS
YEAR-END FINANCIAL RESULTSTotal revenues for the year ended August 31, 2013 were $5.2 million compared to $5.4 million for the previous fiscal year due primarily to a decrease in collaborative research revenue.
Cost of product sales was $6.2 million for the year ended August 31, 2013 compared to $2.4 million for the previous fiscal year. The increase was primarily due to write-down expenses of $2.2 million for obsolete seed inventory relating to the company's sweet sorghum products and $1.7 million for crop management services performed under certain sales incentive and performance-based promotional programs for the 2012-2013 growing season in Brazil.
Research and development expenses decreased by $2.8 million to $16.4 million for the year ended August 31, 2013 compared to the previous fiscal year due primarily to reduced personnel and related expenses in the U.S. as well as reduced external R&D expenses.
Selling, general and administrative expenses were $15.2 million for the year ended August 31, 2013 compared to $12.6 million for the previous fiscal year due primarily to increased personnel and related administrative expenses in Brazil.
For the fiscal year ended August 31, 2013, Ceres reported a net loss of $32.5 million, or $1.31 per share, compared to a net loss of $29.4 million, or $2.18 per share, for the fiscal year ended August 31, 2012.
At August 31, 2013, cash and cash equivalents and marketable securities totaled $30.5 million.
CONFERENCE CALL AND WEBCAST INFORMATIONCeres has scheduled a conference call for 4:30 p.m. EST (1:30 p.m. PST) today to discuss year-end results. The webcast of the conference call may be accessed at investor.ceres.net. Audio of the teleconference is also available by dialing:
North America callers:
+1 (720) 545-0037
An audio replay of the call will be available two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.
ABOUT CERESCeres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.
CERES FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, short-term and long-term business strategies, market and industry expectations, future operating metrics, product yields and future results of operations and financial position, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Ceres' views as of any date subsequent to the date of this press release.CERES, INC. AND SUBSIDIARYCondensed Consolidated Statements of Operations (In thousands, except share and per share amounts)(Unaudited) Three Months Ended
August 31, Year Ended
August 31, 2013201220132012Revenues:Product sales
432Collaborative research and government grants
8981,1645,2435,371Cost and operating expenses:Cost of product sales
1,1325076,2452,384Research and development
3,6173,63416,40119,155Selling, general and administrative
3,4883,67315,18712,634Total cost and operating expenses
8,2377,81437,83334,173Loss from operations
———(84)Loss before income taxes
(7,331)(6,621)(32,510)(29,407)Income tax expense
(29,410)Basic and diluted net loss per share
(2.18)Basic and diluted weighted average outstanding common shares used for net loss per share
24,886,14025,509,94024,796,03013,488,336CERES, INC. AND SUBSIDIARYCondensed Consolidated Balance Sheets (In thousands, except share amounts)August 31,August 31,20132012AssetsCurrent assets:Cash and cash equivalents
20841Other current assets
157278Total current assets
32,43657,568Property and equipment, net
109203Total long-term assets
9,247Liabilities and Stockholders' EquityCurrent liabilities:Accounts payable and accrued expenses
1831Current portion of long-term debt
154134Total current liabilities
9388Long-term debt, net of current portion
4,1726,686Commitments and contingenciesStockholders' equity:Common stock, $0.01 par value; 490,000,000 shares authorized; 24,897,199 shares issued and outstanding at August 31, 2013; 24,549,029 shares issued and outstanding at August 31, 2012.
248245Additional paid-in capital
308,038304,672Accumulated other comprehensive loss
(274,584)(242,073)Total stockholders' equity
33,00662,561Total liabilities and stockholders' equity
|SOURCE Ceres, Inc.|
Copyright©2012 PR Newswire.
All rights reserved